The enhanced nanoplasmonic immunosensor (E-NPIS) enabled the detection of serum SCG2 in small volumes of samples to evaluate its potential as a biomarker for neurodevelopmental disorders. The gene discussed is SCG2; the disease is neurodevelopmental disorder.